BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8638183)

  • 1. Mycobacterium avium-intracellulare complex pneumonia in a non-HIV-infected individual: an increasingly recognized disease.
    Asnis DS; Bresciani AR; Cohn M
    South Med J; 1996 May; 89(5):522-5. PubMed ID: 8638183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
    Fisher M; Tomlinson DR; Coker RJ
    Int J STD AIDS; 1996 Jul; 7(4):244-9; quiz 249-51. PubMed ID: 8876354
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
    Tanaka E; Kimoto T; Tsuyuguchi K; Watanabe I; Matsumoto H; Niimi A; Suzuki K; Murayama T; Amitani R; Kuze F
    Am J Respir Crit Care Med; 1999 Sep; 160(3):866-72. PubMed ID: 10471610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
    Ito Y; Miwa S; Shirai M; Kanai M; Fujita K; Ohba H; Iwaizumi E; Oshima T; Kojima S; Suda T; Hayakawa H
    Respir Med; 2020 Aug; 169():106025. PubMed ID: 32442113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial abscess due to Mycobacterium avium complex in an immunocompetent host: a case report.
    Chowdhary M; Narsinghani U; Kumar RA
    BMC Infect Dis; 2015 Jul; 15():281. PubMed ID: 26201464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
    Kobashi Y; Matsushima T
    Intern Med; 2003 Aug; 42(8):670-5. PubMed ID: 12924489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycobacterium avium infection in a renal transplant recipient].
    Valerga M; Cugliari M; Cefalo E; Martín M
    Enferm Infecc Microbiol Clin; 2007 Apr; 25(4):294-5. PubMed ID: 17386231
    [No Abstract]   [Full Text] [Related]  

  • 10. The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.
    Waller EA; Roy A; Brumble L; Khoor A; Johnson MM; Garland JL
    Chest; 2006 Oct; 130(4):1234-41. PubMed ID: 17035461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
    Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
    Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cavitary pulmonary disease in a patient treated with natalizumab.
    de Masson A; Maillart E; Veziris N; Meyssonnier V; Papeix C; Caumes E
    Presse Med; 2014 Sep; 43(9):1009-12. PubMed ID: 24742610
    [No Abstract]   [Full Text] [Related]  

  • 13. Two faces of MAC-induced lung disease.
    Tetenta S; Abunasser J; Bandyopadhyay T
    Conn Med; 2008 Apr; 72(4):203-5. PubMed ID: 18478985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
    Wallace RJ; Brown BA; Griffith DE; Girard WM; Murphy DT
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1766-72. PubMed ID: 8665032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of infections due to Mycobacterium avium complex.
    Kasperbauer SH; Daley CL
    Semin Respir Crit Care Med; 2008 Oct; 29(5):569-76. PubMed ID: 18810690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Resistance to Ethambutol and Rifampin and Clinical Outcomes in Mycobacterium avium Complex Pulmonary Disease.
    Moon SM; Kim SY; Kim DH; Huh HJ; Lee NY; Jhun BW
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0202721. PubMed ID: 35266825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.
    Bermudez LE; Nash KA; Petrofsky M; Young LS; Inderlied CB
    J Infect Dis; 1996 Dec; 174(6):1218-22. PubMed ID: 8940212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nothing to (S)cough at: Pulmonary Mycobacterium avium Complex Infection.
    Santos MA; Patel H; Albert A
    Am J Med; 2017 Feb; 130(2):153-156. PubMed ID: 27984010
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
    Kim HJ; Lee JS; Kwak N; Cho J; Lee CH; Han SK; Yim JJ
    BMC Pulm Med; 2019 Nov; 19(1):212. PubMed ID: 31711459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mycobacterium avium pneumonia in an HIV negative patient].
    Khanlari B; Burri E; Mihatsch F; Flückiger U; Battegay M
    Internist (Berl); 2007 May; 48(5):527-31. PubMed ID: 17393131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.